Asia-Pacific Liquid Biopsy Market

2.1 Asia-Pacific
      2.1.1 Regional Overview
      2.1.2 Driving Factors for Market Growth
      2.1.3 Factors Challenging the Market
      2.1.4 Test Volume
      2.1.5 Market Size and Forecast
               2.1.5.1 By End User
     2.1.6 China
              2.1.6.1 Test Volume
              2.1.6.2 Market Size and Forecast
                          2.1.6.2.1 By End User
     2.1.7 Japan
              2.1.7.1 Test Volume
              2.1.7.2 Market Size and Forecast
                          2.1.7.2.1 By End User
     2.1.8 India
              2.1.8.1 Test Volume
              2.1.8.2 Market Size and Forecast
                          2.1.8.2.1 By End User
     2.1.9 Australia
              2.1.9.1 Test Volume
              2.1.9.2 Market Size and Forecast
                          2.1.9.2.1 By End User
   2.1.10 South Korea
              2.1.10.1 Test Volume
              2.1.10.2 Market Size and Forecast
                            2.1.10.2.1 By End User
   2.1.11 Singapore
              2.1.11.1 Test Volume
              2.1.11.2 Market Size and Forecast
                            2.1.11.2.1 By End User
   2.1.12 Rest-of-Asia-Pacific
              2.1.12.1 Test Volume
              2.1.12.2 Market Size and Forecast
                            2.1.12.2.1 By End User

3.1 Company Profiles
      3.1.1 Sysmex Corporation
               3.1.1.1 Overview
               3.1.1.2 Top Products
               3.1.1.3 Top Competitors
               3.1.1.4 Key Personnel
               3.1.1.5 Analyst View

4.1 Data Sources
      4.1.1 Primary Data Sources
      4.1.2 Secondary Data Sources
      4.1.3 Data Triangulation
4.2 Market Estimation and Forecast

Table 1: Market Snapshot
Table 2: Asia-Pacific Liquid Biopsy Market, Market Opportunities
Table 3: Product Launches, January 2021-April 2024
Table 4: Some of the Strategic Funding, January 2022-April 2024
Table 5: Launched Liquid Biopsy Tests from Players in the Liquid Biopsy Market
Table 6: Reimbursement Scenario for Key Players' Offerings in the Liquid Biopsy Market
Table 7: Liquid Biopsy Market: Key Players Patent Portfolio
Table 8: Liquid Biopsy Product Mapping Analysis (by Technology)
Table 9: Liquid Biopsy Product Mapping Analysis (by Sample)
Table 10: Liquid Biopsy Product Mapping Analysis (by Circulating Biomarker)
Table 11: Liquid Biopsy Product Mapping Analysis (by Clinical Application)
Table 12: Government Initiatives for Liquid Biopsies
Table 13: Impact Analysis of Market Navigating Factors, 2023-2033
Table 14: Liquid Biopsy Market (by Region), $Million, 2023-2033
Table 15: Asia-Pacific Liquid Biopsy Market (by End User), $Million, 2023-2033
Table 16: China Liquid Biopsy Market (by End User), $Million, 2023-2033
Table 17: Japan Liquid Biopsy Market (by End User), $Million, 2023-2033
Table 18: India Liquid Biopsy Market (by End User), $Million, 2023-2033
Table 19: Australia Liquid Biopsy Market (by End User), $Million, 2023-2033
Table 20: South Korea Liquid Biopsy Market (by End User), $Million, 2023-2033
Table 21: Singapore Liquid Biopsy Market (by End User), $Million, 2023-2033
Table 22: Rest-of-Asia-Pacific Liquid Biopsy Market (by End User), $Million, 2023-2033

Figure 1: Asia-Pacific Liquid Biopsy Market, $Million, 2024, 2028, and 2033
Figure 2: Key Events to Keep Track of in the Liquid Biopsy Market
Figure 3: Impact of COVID-19 on Liquid Biopsy Market
Figure 4: Patent Published (by Country), January 2021-May 2024
Figure 5: Number of Liquid Biopsy Patents (by Year), January 2021-May 2024
Figure 6: Financing Analysis (by Latest Deal Amount), $Million, FY2023-2024
Figure 7: Asia-Pacific Liquid Biopsy Market Scenario, 2023
Figure 8: Frequently Used Technology in Liquid Biopsy
Figure 9: Most Important Factors for Adoption of NGS-Based Liquid Biopsy
Figure 10: Treatment Guidelines for Treatment of Cancer Patients
Figure 11: Major Challenges Faced While Performing Liquid Biopsy
Figure 12: Average Cost of Technologies for the Liquid Biopsy Market (N=30 )
Figure 13: Cost Difference Across Different End Users for the Liquid Biopsy Market
Figure 14: Key Factors for Determining Reimbursement Possibility for the Liquid Biopsy Market
Figure 15: Estimated Cancer Incidence in 2020 and 2040
Figure 16: Estimated New Cancer Cases (2022-2045): Both Sexes, Ages 0-85
Figure 17: Upsurge in Research Publications in Liquid Biopsy, 2015-2023
Figure 18: Comparison of Liquid Biopsy vs. Tissue Biopsy
Figure 19: Asia-Pacific Liquid Biopsy Market, Test Volume, Thousand, 2023-2033
Figure 20: Asia-Pacific Liquid Biopsy Market, $Million, 2023-2033
Figure 21: China Liquid Biopsy Market, Test Volume, Thousand, 2023-2033
Figure 22: China Liquid Biopsy Market, $Million, 2023-2033
Figure 23: Japan Liquid Biopsy Market, Test Volume, Thousand, 2023-2033
Figure 24: Japan Liquid Biopsy Market, $Million, 2023-2033
Figure 25: India Liquid Biopsy Market, Test Volume, Thousand, 2023-2033
Figure 26: India Liquid Biopsy Market, $Million, 2023-2033
Figure 27: Australia Liquid Biopsy Market, Test Volume, Thousand, 2023-2033
Figure 28: Australia Liquid Biopsy Market, $Million, 2023-2033
Figure 29: South Korea Liquid Biopsy Market, Test Volume, Thousand, 2023-2033
Figure 30: South Korea Liquid Biopsy Market, $Million, 2023-2033
Figure 31: Singapore Liquid Biopsy Market, Test Volume, Thousand, 2023-2033
Figure 32: Singapore Liquid Biopsy Market, $Million, 2023-2033
Figure 33: Rest-of-Asia-Pacific Liquid Biopsy Market, Test Volume, Thousand, 2023-2033
Figure 34: Rest-of-Asia-Pacific Liquid Biopsy Market, $Million, 2023-2033
Figure 35: Data Triangulation
Figure 36: Top-Down and Bottom-Up Approach
Figure 37: Assumptions and Limitations